Public Policy Letters and Statements
Human genetics and genomics research is providing remarkable insights into the structure and function of the human genome and how this knowledge can be translated into healthcare advances. This scientific progress relies on continued public investment in biomedical research. ASHG writes letters and statements in support of the Society’s policy priorities as well as joins in coalition with the broader biomedical research advocacy community to support robust, predictable, and sustainable federal research funding to fuel scientific advances.
2024 – Public Letters and Statements
Date | Title | Keywords |
January 7, 2024 | NDD Community Sign-On Letter: Non-Defense Appropriations | Letter; Appropriations |
March 11, 2024 | Ad Hoc Group for Medical Research community letter: Fiscal Year 2025 Recommendation | Letter; Appropriations |
March 12, 2024 | Group Letter Opposing S. 2140, the Patent Eligibility Restoration Act | Letter; Senate Subcommittee on Intellectual Property |
May 2, 2024 | Written Testimony to House Appropriations LHHS Subcommittee for FY 2025 | Letter; Appropriations; NIH |
June 25, 2024 | FY 2025 Coalition for Health Funding/NDD United Community Sign-on Letter | Letter; Appropriations |
July 9, 2024 | Endocrine Society Community Letter re: Fiscal Year (FY) 2025 House LHHS Appropriations Bill/NIH Restructuring | Letter; Appropriations; NIH |
August 2, 2024 | Comments: ASHG Responds to the 21st Century Cures Act and Cures 2.0 Request for Information | Comments; Reps. DeGette & Bucshon |
August 13, 2024 | Comments: ASHG Responds to the Proposed NIH Reform Framework for Discussion | Comments; Chair McMorris Rodgers, House Energy & Commerce |
November 18, 2024 | Ad Hoc Group for Medical Research coalition: Fiscal Year 2025 end-of-year funding recommendation letter | Letter; Appropriations |
November 26, 2024 | Comments: ASHG Responds to the Department of Justice NPRM (Docket No. NSD 104) to implement Executive Order 14117 | Comments; Department of Justice re: Executive Order |
2023 – Public Letters and Statements
Date | Title | Keywords |
January 25, 2023 | Comments: ASHG Conveys to White House the Bioeconomy Benefits, Needs of Genetics Research | Comments; White House |
March 14, 2023 | Ad Hoc Group for Medical Research community letter: Fiscal Year 2024 Recommendation | Letter; Appropriations |
March 23, 2023 | Written Testimony to Congress for FY 2024 | Letter; Appropriations |
May 18, 2023 | Written Testimony to Senate Appropriations LHHS Subcommittee | Letter; Appropriations; LHHS |
October 13, 2023 | Community support letter – Dr. Monica Bertagnolli’s confirmation for NIH Director | Letter; NIH |
December 04, 2023 | Comments Re: FDA Regulatory Oversight of Laboratory Developed Tests | Comments; FDA |
2022 – Public Letters and Statements
Date | Title | Keywords |
March 01, 2022 | Comments Re: ASHG’s Response to an NIH RFI on the Genomic Data Sharing Policy | Comments; NIH |
May 10, 2022 | Ad Hoc Group for Medical Research community letter: Fiscal Year 2023 Recommendation | Letter; Appropriations |
May 11, 2022 | Written Testimony to Congress for FY 2023 | Letter; Appropriations |
May 16, 2022 | Research!America community letter: FY 2023 302(b) funding allocation | Letter; Appropriations |
May 27, 2022 | ASHG Letter to Senate HELP Committee & House E&C Committee: USICA Conference Letter | Letter; Senate HELP; House Energy and Commerce |
September 19, 2022 | Research!America community letter: FY 2023 Appropriations | Letter; Appropriations |
November 8, 2022 | Ad Hoc Group for Medical Research community letter: Urging Swift Passage of FY23 Spending Package | Letter; Appropriations |
2021 – Public Letters and Statements
Date | Title | Keywords |
May 19, 2021 | Written Testimony to Congress for FY 2022 | Letter; Appropriations |
August 6, 2021 | Ad Hoc Group for Medical Research community letter: Fiscal Year 2022 Recommendation | Letter; Appropriations |
2020 – Public Letters and Statements
Date | Title | Keywords |
March 2020 | Written Testimony to Congress for FY 2021 | Letter; Appropriations |
August 6, 2020 | Ad Hoc Group for Medical Research community letter: Covid-19 Related Research Relief | Letter |
December 4, 2020 | Ad Hoc Group for Medical Research community letter: to President-elect Biden | Letter |
2019 – Public Letters and Statements
Date | Title | Keywords |
April 2019 | Written Testimony to Congress for FY 2020 | Letter; Appropriations |